Literature DB >> 15041335

Accommodation in ABO-incompatible kidney transplantation: why do kidney grafts survive?

K Takahashi1.   

Abstract

Owing to the extreme shortage of cadaveric kidneys in Japan, ABO-incompatible kidney transplantation has been performed since 1989. We followed 441 recipients of ABO-incompatible kidney transplants. The long-term outcome did not differ significantly from that in recipients of living donor kidney transplants as a historic control group. Our data provide further evidence that humoral rejection due to ABO-antigen-antibody reaction does not occur once accommodation has been established. This report describes the characteristics of hyperacute and delayed hyperacute rejection as well as the mechanisms whereby accommodation is established in association with changes in donor (graft)-derived ABO histo-blood group glycosyltransferase, appearing in recipient blood after transplantation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15041335     DOI: 10.1016/j.transproceed.2004.01.070

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  9 in total

1.  The effect of desensitization therapy in kidney transplantation.

Authors:  Yong Chul Kim; Mi-Yeon Yu; Jung Pyo Lee; Hajeong Lee; Sang-Il Min; Jongwon Ha; Yon Su Kim
Journal:  Clin Exp Nephrol       Date:  2017-06-20       Impact factor: 2.801

2.  ABO-incompatible renal transplantation: From saline flushes to antigen-specific immunoadsorption-Tools to overcome the barrier.

Authors:  Mario Schiffer; Jan T Kielstein
Journal:  Korean J Hematol       Date:  2011-09-30

3.  Analysis of the Results of ABO-Incompatible Kidney Transplantation: In Comparison with ABO-Compatible Kidney Transplantation.

Authors:  Byung Joo Jeon; In Gon Kim; Youl Keun Seong; Bo Hyun Han
Journal:  Korean J Urol       Date:  2010-12-21

Review 4.  Recent findings in ABO-incompatible kidney transplantation: classification and therapeutic strategy for acute antibody-mediated rejection due to ABO-blood-group-related antigens during the critical period preceding the establishment of accommodation.

Authors:  Kota Takahashi
Journal:  Clin Exp Nephrol       Date:  2007-06-28       Impact factor: 2.801

5.  ABO Incompatible Kidney Transplantation-Current Status and Uncertainties.

Authors:  Milljae Shin; Sung-Joo Kim
Journal:  J Transplant       Date:  2011-12-10

6.  Effects of Neutralization by Soluble ABH Antigens Produced by Transplanted Kidneys From ABO-Incompatible Secretor Donors.

Authors:  Jieun Kim; Sinyoung Kim; In Sik Hwang; Jong Rak Choi; Jae Geun Lee; Yu Seun Kim; Myoung Soo Kim; Hyun Ok Kim
Journal:  Ann Lab Med       Date:  2017-05       Impact factor: 3.464

7.  Late antibody-mediated rejection after ABO-incompatible kidney transplantation during Gram-negative sepsis.

Authors:  Annelies de Weerd; Alieke Vonk; Hans van der Hoek; Marian van Groningen; Willem Weimar; Michiel Betjes; Madelon van Agteren
Journal:  BMC Nephrol       Date:  2014-02-12       Impact factor: 2.388

Review 8.  Desensitization for solid organ and hematopoietic stem cell transplantation.

Authors:  Andrea A Zachary; Mary S Leffell
Journal:  Immunol Rev       Date:  2014-03       Impact factor: 12.988

9.  Treatment of large plasma volumes using specific immunoadsorption to desensitize ABO-incompatible kidney-transplant candidates.

Authors:  Lionel Rostaing; Asma Allal; Arnaud Del Bello; Federico Sallusto; Laure Esposito; Nicolas Doumerc; Bénédicte Debiol; Audrey Delas; Xavier Game; Nassim Kamar
Journal:  J Nephropathol       Date:  2016-06-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.